CD38 and acute lymphoblastic leukemia: CD38-CAR T cells displayed significant cytotoxic activity against cultured CD38high MM, MCL, WM, T-ALL, and NKTCL cells, causing regression of established xenograft tumors from these cells and prolonged animal survival.